Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST - Get Free Report) have been assigned an average rating of "Buy" from the seven research firms that are currently covering the stock, Marketbeat reports.
Read more...